 |
인쇄하기
취소
|
Super Glivec on the phase II study in Korea.
Super Glivec, a second generation of the targeted anti-cancer drug to overcome any resistance, seems to put on the phase II study in Korea.
Prof. Kim Dong-wook, Euijeong-bu St. Mary hospital, the internal hematolgy medicine department, said that he would conduct the phase II study for AMN-107, a second generation of a super Glivec developed by Novartis in Switzerland after the KFDA's approva...
Prof. Kim Dong-wook, Euijeong-bu St. Mary hospital, the internal hematolgy medicine department, said that he would conduct the phase II study for AMN-107, a second generation of a super Glivec developed by Novartis in Switzerland after the KFDA's approva...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.